The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Buys flooding in now folks!!!!!!!!!!!!
Up 26.53%
Astrazeneca contract RNS!
Rececent announcements regarding HER2..........................
Join the dots...........
========================
Also very important about the RNS of 4th Jan "Angle PLC Breakthrough clinical results (5877Y)", see link below.:-
Companies doing Cancer drug trials will NOW want standard blood CtDna analysis ***AND*** Circulating Tumour Cell analysis for even more information on how their extremenly expensive drug trials are doing etc. OF COURSE they will want the maximum information available in order to log for the future and evaluate how their drug is performing!!! The IS A NO BRAINER.
And that is just one of Angle's offerings................................................
https://www.lse.co.uk/rns/AGL/breakthrough-clinical-results-b0km788ah9aflqm.html
All IMHO.
ANGLE is also working to expand its DDR work with other large pharma customers and continues to generate significant new customer interest through its business development activity."
Rampers looking for any news they can jump on, why not.
Hopefully will result in a more meaningful order but with getting on for £2m cash burn per month they will need a lot of £150k orders to fill that.
Contract over 6 months yet represents about 3 days of costs, still hopefully go on to something bigger.
Trls about the time .12.5 million cash and 3 million market cap.
Yipeeee!!!!!!!!
Having taken some time away from this board after wasting too much of my time bickering. It’s nice to see some positive news and with a “large” pharma (hoping not to have to argue what determines a large pharmaceutical company on this one!)
You must be pleased to see Newland (or as you’ve coined him: Nero) starting to make positive steps forward FeverTreeMan, Bantham et al?
Sell off commenced that was quick!
Show me the 💰💰💰💰💰💰
Defo worth a punt at this level…..GLA
Up 32.65%.
Astrazeneca contract!
One can only assume that if this trial is successful it will open ANGLE up to the full AstraZeneca pipeline which is 10's of thousands of patients needing multiple ANGLE test kits...the revenue could be company making!!
Also a big sign of confidence that Astra allowed their name to be used in the RNS they're usually very discreet so it shows confidence that they're happy to be associated with ANGLE. This is incredible news!!
Off now let the rampers do the work for me cya!
Agree need to be two faced at this game never let the idiots know exactly which side of the fence you are playing on..😉
TwoGood2Die you'll be wasting away your precious day here today trying to talk this down. Go outside and enjoy some fresh air. Maybe it will cleanse your soul of all the bitterness your carry inside.
I'm sorry to tell you but your little mouse voice has no impact on the share price here. So no use squeaking any further.
The £150k is simply for the development. It's the revenue that comes after that which counts
I am tempted to but at open and play the ramping game. Played well you make good money on this stock.
'Lie' in 🥕 was it forgot to set the alarm ⏰️ clock lol!
AstraZeneca agreement !
https://www.lse.co.uk/rns/AGL/new-commercial-agreement-with-astrazeneca-edeymgqdtcshqde.html
Agree Pump & Dump III
Where's 🥕?
Too busy dumping lol!
£150k is hopeless.
However, i get how this plays out.
So i reckon this will hit 25p-30p on news like this.
But then we will come back to where we started.
Money to be made if you are brave and quick!
IMHO
Is this deal smaller that the one with Japan's top 3 Pharma I think that was more around £250k mark in size from memory..
These are really tiny deals looking like it's being over ramped by Newland notice the spin around the size of the end market not the likely future deal pipeline with AZ..
Could be being over egged as the financials are going to be diasterous on the share price with concerns over an impending cash placement as that £6m additional revenues target to meet Q2 2025 cash runway extension vaporises!..
£150k doesn't even dent the £6m revenues needed feels more like Newland style spin prior to poor financials release than having any solid commercial substance to it!
Fair points from some people, but I know a "foot in the door" when I see one. ;)
We will all see how this pans out.
Mibb
Brief spike then falls back when financial results released this week?